发明申请
US20140350011A1 Imidazo[4,5-b]pyridine Derivatives as ALK and JAK Modulators for the Treatment of Proliferative Disorders
有权
咪唑并[4,5-b]吡啶衍生物作为ALK和JAK调节剂治疗增殖性疾病
![Imidazo[4,5-b]pyridine Derivatives as ALK and JAK Modulators for the Treatment of Proliferative Disorders](/docs/US/2014-11-27/US20140350011A1/abs.jpg.600x600.jpg)
- 专利标题： Imidazo[4,5-b]pyridine Derivatives as ALK and JAK Modulators for the Treatment of Proliferative Disorders
- 专利标题（中）： 咪唑并[4,5-b]吡啶衍生物作为ALK和JAK调节剂治疗增殖性疾病
-
申请号： US14446411申请日： 2014-07-30
-
公开(公告)号： US20140350011A1公开(公告)日： 2014-11-27
- 发明人: Henry J. Breslin , Matthew A. Curry , Diane E. Gingrich , Keith S. Learn , Gregory R. Ott , Jason C. Wagner
- 申请人： Cephalon, Inc.
- 主分类号： C07D493/08
- IPC分类号： C07D493/08 ; C07D491/107 ; C07D471/04
![Imidazo[4,5-b]pyridine Derivatives as ALK and JAK Modulators for the Treatment of Proliferative Disorders](/abs-image/US/2014/11/27/US20140350011A1/abs.jpg.150x150.jpg)
摘要：
This application relates to compounds of the Formula I as defined herein, and/or salts thereof. This application further relates to compositions and methods of using these compounds and/or salts thereof. The compounds of Formula I are useful as ALK and JAK modulators for the treatment of proliferative disorders.
公开/授权文献
信息查询
